Avandia

Lea en español

AvandiaAvandia (the trade name for Rosiglitazone, marketed by GlaxoSmithKline (GSK)), is a drug approved in 1999 for treatment of type 2 diabetes. The product was used extensively until 2007, when a report in the New England Journal of Medicine linked it with studies showing an increased risk of heart attack. The patent on the drug expired in 2012.
In addition to heart disease, Avandia has been linked to numerous other health concerns, including:

  • Increased risk of stroke
  • Greater susceptibility to bone fractures
  • Excessive weight gain
  • Loss of vision and other eye disease
  • Low blood sugar
  • Moderate to acute hepatitis

There’s evidence that GSK knew of the heart attack risks and covered up what they knew. There’s also evidence that the company threatened researchers who reported any adverse health effects tied to the drug.

If you or someone you love has suffered injury after taking Avandia, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.

Defective Drugs & Medical Devices Topics

Latest Articles

Divorce and Taxes

  If you are facing a divorce, you know that there are plenty of difficult, even painful questi…

07 Dec 2018, Friday

Legalizing Recreational Marijuana: A New State Revolution?

  Election night 2018 brought about several changes in the legal landscape, but probably none s…

06 Dec 2018, Thursday

The State(s) of Medicaid Expansion

  In 2012, the Patient Protection and Affordable Care Act (“ACA”) made some sweeping chang…

05 Dec 2018, Wednesday